PT1156795E - Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina - Google Patents

Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina

Info

Publication number
PT1156795E
PT1156795E PT99933301T PT99933301T PT1156795E PT 1156795 E PT1156795 E PT 1156795E PT 99933301 T PT99933301 T PT 99933301T PT 99933301 T PT99933301 T PT 99933301T PT 1156795 E PT1156795 E PT 1156795E
Authority
PT
Portugal
Prior art keywords
succinic acid
insulin resistance
salts
treating insulin
methods
Prior art date
Application number
PT99933301T
Other languages
English (en)
Inventor
Olga Evgenievna Kolesova
Igor Anatolievich Pomytkin
Tatiyana Jurievna Ukhanova
Original Assignee
Pavel Vasilievich Verteletsky
Igor Anatolievich Pomytkin
Tatiyana Jurievna Ukhanova
Olga Evgenievna Kolesova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pavel Vasilievich Verteletsky, Igor Anatolievich Pomytkin, Tatiyana Jurievna Ukhanova, Olga Evgenievna Kolesova filed Critical Pavel Vasilievich Verteletsky
Publication of PT1156795E publication Critical patent/PT1156795E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
PT99933301T 1999-03-01 1999-03-01 Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina PT1156795E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1999/000055 WO2000051594A1 (en) 1999-03-01 1999-03-01 Use of succinic acid or salts thereof and method of treating insulin resistance

Publications (1)

Publication Number Publication Date
PT1156795E true PT1156795E (pt) 2004-09-30

Family

ID=20130328

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99933301T PT1156795E (pt) 1999-03-01 1999-03-01 Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina

Country Status (10)

Country Link
US (1) US6521665B1 (pt)
EP (1) EP1156795B1 (pt)
AT (1) ATE268170T1 (pt)
AU (1) AU4937499A (pt)
CA (1) CA2366073A1 (pt)
DE (1) DE69917809T2 (pt)
DK (1) DK1156795T3 (pt)
ES (1) ES2222717T3 (pt)
PT (1) PT1156795E (pt)
WO (1) WO2000051594A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2404864A1 (en) * 2000-04-10 2001-10-18 Tatiyana Jurievna Ukhanova Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes
KR20100031763A (ko) * 2007-08-02 2010-03-24 부다 바이오파마 오와이 리미티드 숙신산을 포함하는 비강내 투여용 약학 조성물 및 이를 이용한 예방 치료방법
CN102472757B (zh) * 2009-07-15 2014-12-17 松下健康医疗器械株式会社 分析用试剂
JP5460183B2 (ja) * 2009-08-28 2014-04-02 パナソニック株式会社 分析用試薬および分析用デバイス
WO2019244133A1 (en) * 2018-06-22 2019-12-26 Enzene Biosciences Limited Succinic acid and derivatives for the treatment of haemotological disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61171417A (ja) * 1985-01-23 1986-08-02 Wakunaga Seiyaku Kk 抗糖尿病剤
JP3581157B2 (ja) * 1992-08-19 2004-10-27 株式会社ミツカングループ本社 低耐糖能者用食品

Also Published As

Publication number Publication date
US6521665B1 (en) 2003-02-18
EP1156795B1 (en) 2004-06-02
ATE268170T1 (de) 2004-06-15
ES2222717T3 (es) 2005-02-01
DE69917809T2 (de) 2004-11-04
CA2366073A1 (en) 2000-09-08
WO2000051594A1 (en) 2000-09-08
AU4937499A (en) 2000-09-21
DK1156795T3 (da) 2004-11-01
DE69917809D1 (de) 2004-07-08
EP1156795A1 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
BR0112750A (pt) Aminopiperidina quinolinas e seus análogos azaisostéricos com atividade antibacteriana
DK0806941T3 (da) Liposomalt antibakterielt præparat med lav fasthed
PT950057E (pt) Enantiomeros de 3-piridilo e sua utilizacao como analgesicos
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
PT1156795E (pt) Utilizacao de acido succinico ou de seus sais e metodo de tratamento da resistencia a insulina
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
BR9708525A (pt) Método de tratamento de insuficência cardíaca com antagonistas de endotelina
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
DE602006020838D1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
AP2000001937A0 (en) Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway.
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
PT1362590E (pt) Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
WO2003103699A8 (en) USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS
EA199800819A1 (ru) Способ лечения биполярного расстройства
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
DE60236927D1 (de) Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections